INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

GRALGRAIL, Inc.

CIK 0001699031

EDGAR filingsOpen in network
Disclosed transactions17
Buys / sells0 / 15
Max Insider Score40
Connections14with evidence

GRAL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
40
FA
Freidin AaronChief Financial Officer
GRALGRAIL, Inc.
Open-market sale
SELL$3.46M
23.6K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8071 · Services-Medical Laboratories · Nov 4, 2026
  • ← Connected organizationevidence
    GRAIL, INC. PACFEC Form 1 connected organization: GRAIL, INC. (exact legal-name match) · Nov 4, 2026
  • ← Insider ofevidence
    Partridge Andrew JohnChief Growth Officer · Oct 7, 2026
  • ← Insider ofevidence
    Ofman Joshua J.Director, Chief Executive Officer · Aug 31, 2026
40
PJ
Partridge Andrew JohnChief Growth Officer
GRALGRAIL, Inc.
Open-market sale
SELL
$1.15M
7,873 sh
Oct 5, 2026
Oct 7, 2026
traded Oct 5, 2026
+2d
SEC FORM 4

Evidence

7
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Option exercise · 10b5-1 plan
M—
26.5K sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

14
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$211K
2,100 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

20
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$1.10M
10.0K sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

14
FA
Freidin AaronChief Financial Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$164K
1,779 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

14
FA
Freidin AaronChief Financial Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$169K
1,800 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

11
FA
Freidin AaronChief Financial Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
521 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

5
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Option exercise · 10b5-1 plan
M$370K
26.5K sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

14
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
2,125 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

14
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$136K
1,454 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

24
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$3.59M
37.8K sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

17
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$598K
6,200 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

14
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$137K
1,400 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

11
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
421 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

16
FA
Freidin AaronChief Financial Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$672K
7,900 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

16
OJ
Ofman Joshua J.Director, Chief Executive Officer
GRALGRAIL, Inc.
Open-market sale · 10b5-1 plan
SELL$425K
5,000 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Freidin AaronChief Financial Officer · Aug 31, 2026
  • ← Lobbied forevidence
    THE MCMANUS GROUPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    WILLIAMS AND JENSEN, PLLCLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    MARSHALL & POPP, LLCLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    AVENUE SOLUTIONSLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    MILLER STRATEGIES, LLCLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    FORBES-TATELDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    GRANT PARK STRATEGIESLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    THE HARPLE GROUP, LLCLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK HEALTH STRATEGIES, INC.LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026

    • Lobbying

    $840K reported · de-duplicated
    2026 Q2 $410K via firms2026 Q1 $430K via firms
    • WILLIAMS AND JENSEN, PLLC$50K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • MARSHALL & POPP, LLC$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • AVENUE SOLUTIONS$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • MILLER STRATEGIES, LLC$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • TIBER CREEK HEALTH STRATEGIES, INC.$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • FORBES-TATE$50K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • GRANT PARK STRATEGIES$30K2026 Q2 · posted Aug 26, 2026 · Health issues
    • THE HARPLE GROUP, LLC$30K2026 Q1 · posted Aug 26, 2026 · Health issues
    • THE MCMANUS GROUP$50K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • FORBES-TATE$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • THE HARPLE GROUP, LLC$10K2026 Q2 · posted Aug 26, 2026 · Health issues
    • WILLIAMS AND JENSEN, PLLC$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Hakeem S. JeffriesD$10KGRAIL, INC. PAC
    • Jason SmithR$10KGRAIL, INC. PAC
    • Katherine M. ClarkD$10KGRAIL, INC. PAC
    • Mike JohnsonR$10KGRAIL, INC. PAC
    • Steve ScaliseR$10KGRAIL, INC. PAC
    • Mariannette Miller-Meeks
    R
    $9,000
    GRAIL, INC. PAC
  • Terri A. SewellD$7,500GRAIL, INC. PAC
  • Richard HudsonR$7,000GRAIL, INC. PAC
  • Raul RuizD$5,500GRAIL, INC. PAC
  • Jodey C. ArringtonR$5,000GRAIL, INC. PAC
  • Brett GuthrieR$5,000GRAIL, INC. PAC
  • Mike CrapoR$5,000GRAIL, INC. PAC
    • Source error

    Price history for GRAL is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.